NeuroOne Medical Technologies
(NASDAQ) NMTC
NeuroOne Medical Technologies Financials at a Glance
Market Cap
$29.07M
Revenue (TTM)
$9.72M
Net Income (TTM)
-$6.64M
EPS (TTM)
-$0.83
P/E Ratio
-4.02
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Price
$3.28
Volume
89,812.349
Open
$3.17
Price
$3.28
Volume
89,812.349
Open
$3.17
Previous Close
$3.34
Daily Range
$3.17 - $3.36
52-Week Range
$3.08 - $6.96
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
0.89 (Low)
Price
$3.28
Volume
89,812.349
Open
$3.17
Previous Close
$3.34
Daily Range
$3.17 - $3.36
52-Week Range
$3.08 - $6.96
Estimated Earnings Date
Aug 13, 2026
NMTC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout NeuroOne Medical Technologies
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
18
CEO
David A. Rosa, MBA
Website
nmtc1.comHeadquarters
Eden Prairie, MN 55344, US
NMTC Financials
Key Financial Metrics (TTM)
Gross Margin
54.50%
Operating Margin
-72.69%
Net Income Margin
-68.34%
Return on Equity
-98.33%
Return on Capital
-57.59%
Return on Assets
-84.47%
Earnings Yield
-24.88%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$29.07M
Shares Outstanding
8.70M
Volume
89.81K
Avg. Volume
38.88K
Financials (TTM)
Gross Profit
$5.30M
Operating Income
-$7.07M
EBITDA
-$6.38M
Operating Cash Flow
-$7.43M
Capital Expenditure
-$133.43K
Free Cash Flow
-$7.57M
Cash & ST Invst.
$2.80M
Total Debt
$206.97K
NeuroOne Medical Technologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.39M
+72.5%
Gross Profit
$1.29M
+66.9%
Gross Margin
53.81%
N/A
Market Cap
$29.07M
N/A
Market Cap/Employee
$1.71M
N/A
Employees
17
N/A
Net Income
-$2.09M
+8.1%
EBITDA
-$2.03M
+8.1%
Quarterly Fundamentals
Total Cash
$2.80M
+112.4%
Total Debt
$206.97K
-33.5%
Accounts Receivable
$2.43M
+661.2%
Inventory
$1.87M
+1.7%
Long Term Debt
$92.36K
-55.4%
Short Term Debt
$114.61K
+9.7%
Return on Assets
-84.47%
N/A
Return on Invested Capital
-1.14%
N/A
Free Cash Flow
-$1.37M
-2205.0%
Operating Cash Flow
-$1.33M
-2266.6%